Big tech's involvement in public scientific research does more harm than good

Overview Debates Related claims Topics Sources

Inquiry chair Kate Lampard is considering issuing interim regulations and recommendations regarding Oxevision camera technology to prevent further avoidable patient deaths.

Lawyers representing over 70 bereaved families urged the Lampard Inquiry on October 20, 2026 to recommend a national ban on Oxevision in NHS mental health inpatient wards.

In the encyclical Magnifica Humanitas, Pope Leo XIV called for disarming artificial intelligence to free the technology from logics of domination, exclusion, and war.

India's Ministry of Health launched the Strategy for Artificial Intelligence in Healthcare for India in February 2026 to govern data, validation, deployment, and monitoring.

A report by the European Academies Science Advisory Council and the Federation of European Academies of Medicine recommended that high-risk artificial intelligence systems in healthcare remain under strict human supervision.

Pope Leo XIV published the encyclical Magnifica Humanitas in May 2026 calling for artificial intelligence to serve human dignity, social justice, and vulnerable populations.

EHR vendors should be required to provide open access to third-party AI tools

Public-private partnerships are the most effective way to build foundational scientific datasets

The US government's $500 million investment in AI biological modeling is justified

The Utah Medical Licensing Board previously issued an open letter opposing an earlier pilot by Doctronic, stating they were not consulted and that the program placed citizens at risk.

To address legal ambiguities, the Office of Artificial Intelligence Policy requires a special malpractice insurance covering AI-generated prescriptions and builds specific duty of care provisions into contracts.

Utah's Artificial Intelligence Learning Laboratory, or AI sandbox, was established by state law in 2024 to allow the Office of Artificial Intelligence Policy to waive regulations for testing AI products.

Utah's Office of Artificial Intelligence Policy approved a plan on October 5, 2026, allowing an artificial intelligence product to evaluate patients and write new drug prescriptions without direct human oversight.

The Utah Office of Artificial Intelligence Policy approved three new healthcare AI pilots on October 2, 2026, covering acne prescription, chronic condition drug renewals, and virtual pelvic floor therapy.

Utah's regulatory sandbox is an appropriate way to foster healthcare innovation

The Office of Artificial Intelligence Policy signed master agreements in September 2026 with University of Utah Health and Intermountain Health to set terms for potential future AI pilots.

The federal government should aggregate public health data for external AI research

NHS England stated that any vision-based monitoring technology must support a human rights-based approach to care and comply with legal requirements and patient consent.

The Medicare artificial intelligence pilot program does not currently impose prior authorization requirements on chronic obstructive pulmonary disease medications.

The study authors acknowledged uncertainty regarding whether the studied AI models qualify as moral patients and advocated for the development of ethical standards for AI welfare research.